Debt-to-equity of BIORA THERAPEUTICS, INC. from 31 Mar 2021 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
BIORA THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2021 to 30 Sep 2024.
  • BIORA THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2024 was -122%, a 15% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

BIORA THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2024 -122% +21% +15% 30 Sep 2024
Q2 2024 -126% +25% +17% 30 Jun 2024
Q1 2024 -131% +30% +19% 31 Mar 2024
Q4 2023 -138% +34% +20% 31 Dec 2023
Q3 2023 -143% +47% +25% 30 Sep 2023
Q2 2023 -151% +31% +17% 30 Jun 2023
Q1 2023 -161% +22% +12% 31 Mar 2023
Q4 2022 -172% +14% +7.7% 31 Dec 2022
Q3 2022 -190% +0.98% +0.51% 30 Sep 2022
Q2 2022 -182% +39% +18% 30 Jun 2022
Q1 2022 -184% +106% +37% 31 Mar 2022
Q4 2021 -186% 31 Dec 2021
Q3 2021 -191% 30 Sep 2021
Q2 2021 -221% 30 Jun 2021
Q1 2021 -290% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.